Connectus Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Connectus Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$492K	Sell	5,180 -150	-3%	-$13.9K	0.01%	289
2023 Q4	$476K	Hold	5,330	–	–	0.01%	408
2023 Q3	$389K	Sell	5,330 -560	-10%	-$44.7K	0.01%	406
2023 Q2	$490K	Sell	5,890 -9,535	-62%	-$797K	0.01%	354
2023 Q1	$1.18M	Buy	15,425 +10,048	+187%	+$834K	0.03%	272
2022 Q4	$446K	Sell	5,377 -500	-9%	-$40.5K	0.01%	348
2022 Q3	$467K	Sell	5,877 -805	-12%	-$67.9K	0.01%	412
2022 Q2	$496K	Buy	+6,682	New	+$502K	0.01%	334

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Connectus Wealth's XBI Position: Q1 2024 in Review

Connectus Wealth reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.8% in Q1 2024, selling an estimated $13.9K and leaving 5,180 shares worth $492K. The position accounts for 0.01% of the portfolio, ranked #289.

Connectus Wealth first reported a position in XBI in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.18M in Q1 2023. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Connectus Wealth held 5,180 shares of State Street SPDR S&P Biotech ETF worth $492K as of Q1 2024.
Connectus Wealth sold 150 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $13.9K.
State Street SPDR S&P Biotech ETF made up 0.01% of Connectus Wealth's portfolio in Q1 2024, its #289 holding.
Connectus Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 8 quarters since.
Connectus Wealth's State Street SPDR S&P Biotech ETF position peaked at $1.18M in Q1 2023.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.